What is Medline, Inc. 's market cap?

Medline, Inc. (MDLN) has a market capitalization of $34.5B and trades on NASDAQ.

What is Medline, Inc. 's revenue and profitability?

Medline, Inc. generated $26.7B in trailing twelve-month revenue with net income of $841.8M, representing a net margin of 4.6%. Gross margin stands at 27.4%, with free cash flow of $1.6B. These figures are based on the Q1 2026 filing.

Who are Medline, Inc. 's competitors?

Medline, Inc. 's key competitors include Cardinal Health, McKesson, Becton, Dickinson and Company, and others. These companies compete in similar markets and product categories.

What subsidiaries does Medline, Inc. have?

Medline, Inc. 's subsidiaries include MedTrans.

Where is Medline, Inc. headquartered?

Medline, Inc. is headquartered in United States of America. It has been publicly traded since 2025.

Medline, Inc.

MDLN

Medline Inc. is the largest provider of medical-surgical products and supply chain solutions, serving the full continuum of healthcare from hospitals to post-acute facilities.

Market cap

$34.54B+10.3%

Revenue$26.7B+9.8%

Net income$841.8M-9.6%

Free cash flow$1.6B+13.8%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 6, 2026

Revenue$7.4BBeat by $189.4M EPS$0.33Beat by $0.03

Read the full report

Next report

Aug 5, 2026 (In 3 weeks)

Revenue estimate$7.5B

EPS estimate$0.32

Financials

Q1 2026

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation & ratios

Valuation

See full

Market cap$34.54B+10.3%

Enterprise value$44.87B—

P/E41×—

P/S1.3×—

Returns & leverage

See full

Debt / equity1.1×—

Current ratio4.4×—

Segments

By product

See full

Front Line Care$1.6B+6.0%

Surgical Solutions$1.6B+7.4%

Laboratory and Diagnostics$293.0M+0.7%

By segment

See full

Supply Chain Solutions$3.9B+15.0%

Medline Brand$3.5B+6.2%

By geography

See full

International$495.0M+10.0%

Competitors

By market cap

McKesson$92.8B+1.1%

Cardinal Health$54.8B+36.8%

Becton, Dickinson and Company$41.6B-16.1%

Medline, Inc. $34.5B—

Solventum$13.2B-0.3%

Baxter International$11.6B-23.9%

Henry Schein$9.6B+4.0%

UFP Technologies$1.9B+4.0%

By revenue growth

Cardinal Health+12.8%

McKesson+12.4%

UFP Technologies+11.2%

Medline, Inc. +9.8%

Becton, Dickinson and Company+6.4%

Henry Schein+5.6%

Baxter International+5.1%

Solventum-0.5%

By net margin

Solventum17.33%+12.8pp

UFP Technologies11.27%-0.3pp

Becton, Dickinson and Company5.33%-2.1pp

Medline, Inc. 4.62%-0.7pp

Henry Schein2.95%-0.3pp

McKesson1.18%+0.3pp

Cardinal Health0.62%-0.1pp

Baxter International-9.7%-4.5pp

Profile

Medline Inc. is the largest provider of medical-surgical products and supply chain solutions, serving the full continuum of healthcare from hospitals to post-acute facilities. The company operates an integrated business model as both a manufacturer and a distributor, leveraging a proprietary logistics network and a Prime Vendor model to drive clinical and operational efficiencies for healthcare providers.

Competitive position

Medline is the leading provider of med-surg products by net sales, distinguished by its vertical integration as both a manufacturer and a primary logistics partner.

GeographiesUnited States, North America, Europe, Asia-Pacific

Customer segmentsAcute care hospitals, Ambulatory surgery centers, Physician offices, Long-term care facilities

Business modelVertical integration, Manufacturing, Wholesale distribution, B2B services

SuppliersRaw material suppliers, Component manufacturers, Third-party med-surg product manufacturers, Sterilization service providers

CustomersHospitals, Clinics, Nursing homes, Diagnostic laboratories

CountryUnited States of America

Listed2025

CEOJames Boyle

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websitemedline.com

FilingsSEC EDGAR

Ask your AI about Medline, Inc. .

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's market cap?: Medline, Inc. (MDLN) has a market capitalization of $34.5B and trades on NASDAQ.
What is Medline, Inc. 's revenue and profitability?: Medline, Inc. generated $26.7B in trailing twelve-month revenue with net income of $841.8M, representing a net margin of 4.6%. Gross margin stands at 27.4%, with free cash flow of $1.6B. These figures are based on the Q1 2026 filing.
Who are Medline, Inc. 's competitors?: Medline, Inc. 's key competitors include Cardinal Health, McKesson, Becton, Dickinson and Company, and others. These companies compete in similar markets and product categories.
What subsidiaries does Medline, Inc. have?: Medline, Inc. 's subsidiaries include MedTrans.
Where is Medline, Inc. headquartered?: Medline, Inc. is headquartered in United States of America. It has been publicly traded since 2025.